Retaglutide is a innovative GLP-1 receptor agonist currently under research for the control of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://sahiljpxr010202.bleepblogs.com/39345694/retaglutide-a-promising-glp-1-receptor-agonist